| |
 |
Drugs Acting on the Beta Isoform of Human Topoisomerase II (p180)
|
| |
|
pp.173-185 (13) Authors: B. Gatto, E. Leo |
| |
|
|
| |
|
The Interaction of Histone Deacetylase Inhibitors and DNA Methyltransferase Inhibitors in the Treatment of Human Cancer Cells
|
| |
|
pp.187-199 (13) Authors: Wei-Guo Zhu, Gregory A. Otterson |
| |
|
|
| |
|
Signal Transduction Inhibitors in the Treatment of Breast Cancer
|
| |
|
pp.201-216 (16) Authors: Rita Nahta, Gabriel N. Hortobagyi, Francisco J. Esteva |
| |
|
|
| |
|
The BCL2-Family of Protein Ligands as Cancer Drugs: The Next Generation of Therapeutics
|
| |
|
pp.217-223 (7) Authors: WenJing Liu, Anca Bulgaru, Missak Haigentz, C. A. Stein, Roman Perez-Soler, Sridhar Mani |
| |
|
|
| |
|
Pharmacogenetics of Irinotecan
|
| |
|
pp.225-237 (13) Authors: G. Toffoli, E. Cecchin, G. Corona, M. Boiocchi |
| |
|
|
| |
|
Peroxisome Proliferator Activated Receptor-Gamma Ligands as Potent Antineoplastic Agents
|
| |
|
pp.239-251 (13) Authors: S. Theocharis, A. Margeli, G. Kouraklis |
| |
|
|
